
Koninklijke Philips N.V. (PHIA:AEX) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends
Description
Koninklijke Philips N.V. (PHIA:AEX) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends
Report Summary
Year End Offer - Buy Now and get an updated version of this Report at no extra cost within 30 days of the release of Company's next Annual Report. (Offer expires on 31st Dec 2024)
Koninklijke Philips N.V. (PHIA:AEX) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report is a comprehensive and easily accessible overview of Koninklijke Philips N.V.'s business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Koninklijke Philips N.V. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Koninklijke Philips N.V.'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Koninklijke Philips N.V.'s overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Koninklijke Philips N.V.'s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Koninklijke Philips N.V.'s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Koninklijke Philips N.V. enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Koninklijke Philips N.V. operates as a health technology company. Koninklijke Philips N.V. operates in three main business segments: Diagnosis and Treatment, Connected Care, and Personal Health. Koninklijke Philips N.V. offers a wide range of health technology products and services including diagnostic imaging solutions, patient monitoring systems, sleep and respiratory care solutions, dental care products, grooming and beauty products, and more. The company aims to improve people's health and wellbeing through meaningful innovation across healthcare, consumer lifestyle, and lighting. Founded in 1891, the company is headquartered in Amsterdam, North Holland, Netherlands.
Koninklijke Philips N.V. in the News:-
- 07-May-2024 - Philips shareholders approve all proposals at the AGM 2024
- 30-Apr-2024 - Nicklaus Children’s Health System, Philips to provide innovative patient and staff experience, helping to enhance outcomes for the smallest of patients
- 19-Apr-2024 - Philips Museum opens new exhibition brAInpower on artificial intelligence
- 04-Apr-2024 - Philips Foundation and March of Dimes partner to improve prenatal care access in underserved communities, helping address US maternal and infant health challenges
- 19-Mar-2024 - Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
- Comprehensive Understanding of the Koninklijke Philips N.V.'s internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
- Koninklijke Philips N.V. Value Chain Analysis
- Koninklijke Philips N.V. Porter's Five Forces Analysis
- Koninklijke Philips N.V. VRIO Analysis
- Koninklijke Philips N.V. BCG Analysis
- Koninklijke Philips N.V. Segmentation, Targeting and Positioning (STP) Analysis
- Koninklijke Philips N.V. Ansoff Matrix Analysis
Table of Contents
109 Pages
- COMPANY EXECUTIVE SUMMARY
- Tables
- Charts
- Koninklijke Philips N.V.-Key Company Facts
- Koninklijke Philips N.V.- Company Description
- Koninklijke Philips N.V.- Top Executives
- Koninklijke Philips N.V.- Head Office & Locations
- Head Office - Country
- Koninklijke Philips N.V.- Productsand Services
- Products
- Services
- Koninklijke Philips N.V.- Corporate Strategy
- Koninklijke Philips N.V.- Business Description
- Diagnosis & Treatment segment
- Connected Care
- Personal Health
- Koninklijke Philips N.V.- ESG Spotlight
- Environment
- Social
- Corporate Governance
- Koninklijke Philips N.V.- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Koninklijke Philips N.V.- PESTLE Analysis
- Overview
- Political Factors
- Economic Factors
- Social Factors
- Technological Factors
- Legal Factors
- Environmental Factors
- Koninklijke Philips N.V.- Financial Deep Dive
- Share Price Trend - Nov-2023 to Nov-2024 (Average Share Closing Price)
- Profit and Loss Statement
- Summary of Profit and Loss Statement
- Balance Sheet
- Summary of Balance Sheet
- Cash Flow Statement
- Summary of Cash Flow Statement
- Key Financial Ratio Analysis
- Koninklijke Philips N.V.- Ratio Charts
- Activity Ratio Charts
- Growth Ratios Charts
- Leverage Ratio Charts
- Liquidity Ratio Charts
- Profitability Ratio Charts
- Competing Players
- Snapshot of Competing Players
- Abbott Laboratories
- Key Company Facts
- Company Description
- Becton, Dickinson and Company
- Key Company Facts
- Company Description
- Canon Inc.
- Key Company Facts
- Company Description
- Hologic, Inc.
- Key Company Facts
- Company Description
- Siemens Healthineers AG
- Key Company Facts
- Company Description
- Koninklijke Philips N.V. - In the News
- 7-May-2024 -Philips shareholders approve all proposals at the AGM 2024
- 30-Apr-2024 -Nicklaus Children's Health System, Philips to provide innovative patient and staff experience, helping to enhance outcomes for the smallest of patients
- 19-Apr-2024 -Philips Museum opens new exhibition brAInpower on artificial intelligence
- 4-Apr-2024 -Philips Foundation and March of Dimes partner to improve prenatal care access in underserved communities, helping address US maternal and infant health challenges
- 19-Mar-2024 -Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office
- 29-Feb-2024 -Philips teams with Synthetic MR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients at #ECR2024
- 28-Feb-2024 -Philips launches high-power and fast motorized mobile C-arm, the Zenition 90 Motorized, designed to help surgeons deliver high-quality care to patients at #ECR2024
- 28-Feb-2024 -Philips extends leadership in virtually helium-free MRI with more than 1,000 systems installed, expanding patient access worldwide
- 28-Feb-2024 -Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips' Chief Financial Officer (CFO)
- 20-Feb-2024 -Philips proposes to re-appoint Chairman Feike Sijbesma and Peter Löscher and nominates Benoît Ribadeau-Dumas as member of the Supervisory Board
- 9-Feb-2024 -Philips introduces AI-enabled diagnostic imaging and treatment innovations to help improve patient care at #ECR2024
- Koninklijke Philips N.V. - Key Deals
- 2-May-2024 - Radboud University Medical Center and Philips sign 10-year patient monitoring partnership and agreement to keep software state-of-the-art
- 10-Apr-2024 - Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward
- 4-Apr-2024 - Philips and smartQare partner to automate and simplify continuous patient monitoring in and out of the hospital
- 4-Nov-2023 - Philips and Northwell Health partner to standardize and future-proof patient monitoring across the enterprise
- 2-Nov-2023 - Philips and County Durham and Darlington NHS Foundation Trust collaborate on a sustainability blueprint to reduce carbon emissions and waste
- 15-Mar-2023 - Champalimaud Foundation partners with Philips to reduce its diagnostic imaging carbon footprint by 50% in five years
- 14-Mar-2023 - Philips and Gibraltar Health Authority announce 16-year strategic partnership, transforming patient imaging and cardiac care at St Bernard's Hospital
- 12-Mar-2023 - Philips and AWS collaborate to scale digital pathology in the cloud, enhancing diagnostic capabilities and improving productivity
- 9-Feb-2023 - Philips and TriHealth announce multi-year partnership at heart of new TriHealth Heart & Vascular Institute on the campus of Bethesda North Hospital
- 7-Feb-2023 - Philips and Candid partner to offer dental professionals a more effective and efficient orthodontic solution
- Appendix
- Definitions
- SWOT Analysis
- PESTLE Analysis
- Value Chain Analysis
- ESG Spotlight
- Financial Deep Dive
- Financial Ratios-
- Activity Ratios
- Growth Ratios
- Leverage Ratios
- Liquidity Ratios
- Market Ratios
- Profitability Ratios
- Research Methodology
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.